4.5 Article

Inter-lab concordance of variant classifications establishes clinical validity of expanded carrier screening

Related references

Note: Only part of the references are listed.
Article Genetics & Heredity

A data-driven evaluation of the size and content of expanded carrier screening panels

Rotem Ben-Shachar et al.

GENETICS IN MEDICINE (2019)

Article Genetics & Heredity

Clinical utility of expanded carrier screening: results-guided actionability and outcomes

Katherine A. Johansen Taber et al.

GENETICS IN MEDICINE (2019)

Article Genetics & Heredity

Systematic design and comparison of expanded carrier screening panels

Kyle A. Beauchamp et al.

GENETICS IN MEDICINE (2018)

Article Genetics & Heredity

Updated recommendation for the benign stand-alone ACMG/AMP criterion

Rajarshi Ghosh et al.

HUMAN MUTATION (2018)

Review Genetics & Heredity

Fragile X syndrome: An overview and update of the FMR1 gene

M. Mila et al.

CLINICAL GENETICS (2018)

Article Genetics & Heredity

Clinical laboratories collaborate to resolve differences in variant interpretations submitted to ClinVar

Steven M. Harrison et al.

GENETICS IN MEDICINE (2017)

Article Multidisciplinary Sciences

Systematic Classification of Disease Severity for Evaluation of Expanded Carrier Screening Panels

Gabriel A. Lazarin et al.

PLOS ONE (2014)

Review Respiratory System

Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice

C. Castellani et al.

JOURNAL OF CYSTIC FIBROSIS (2008)